Clinical Trial Update: FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

FT836 is being studied in a Phase 1 trial for advanced solid tumors, administered with or without chemotherapy and/or monoclonal antibodies. The trial covers mu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Endometrial Cancer
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Ovarian Cancer

Drugs mentioned

• FT836

Snippet

Sponsor: Fate Therapeutics | Conditions: Non-Small Cell Lung Cancer, Colorectal Cancer | Phase 1 | Status: RECRUITING